Croxford JL - Search Results

1

Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system.

Croxford JL, Triantaphyllopoulos K, Podhajcer OL, Feldmann M, Baker D, Chernajovsky Y. Croxford JL, et al. J Immunol. 1998 May 15;160(10):5181-7. J Immunol. 1998. PMID: 9590271

2

Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis.

Triantaphyllopoulos K, Croxford J, Baker D, Chernajovsky Y. Triantaphyllopoulos K, et al. Gene Ther. 1998 Feb;5(2):253-63. doi: 10.1038/sj.gt.3300570. Gene Ther. 1998. PMID: 9578846

3

Polygenic control of experimental allergic encephalomyelitis in Biozzi ABH and BALB/c mice.

Croxford JL, O'Neill JK, Baker D. Croxford JL, et al. J Neuroimmunol. 1997 Apr;74(1-2):205-11. doi: 10.1016/s0165-5728(96)00219-6. J Neuroimmunol. 1997. PMID: 9119975

4

Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis.

Croxford JL, O'Neill JK, Ali RR, Browne K, Byrnes AP, Dallman MJ, Wood MJ, Fedlmann M, Baker D. Croxford JL, et al. Eur J Immunol. 1998 Dec;28(12):3904-16. doi: 10.1002/(SICI)1521-4141(199812)28:12<3904::AID-IMMU3904>3.0.CO;2-5. Eur J Immunol. 1998. PMID: 9862327 Free article.

5

Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor.

Croxford JL, Triantaphyllopoulos KA, Neve RM, Feldmann M, Chernajovsky Y, Baker D. Croxford JL, et al. J Immunol. 2000 Mar 1;164(5):2776-81. doi: 10.4049/jimmunol.164.5.2776. J Immunol. 2000. PMID: 10679120

6

Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system.

Croxford JL, Feldmann M, Chernajovsky Y, Baker D. Croxford JL, et al. J Immunol. 2001 Mar 15;166(6):4124-30. doi: 10.4049/jimmunol.166.6.4124. J Immunol. 2001. PMID: 11238662

7

Gene therapy for rheumatoid arthritis. Theoretical considerations.

Chernajovsky Y, Annenkov A, Herman C, Triantaphyllopoulos K, Gould D, Dreja H, Moyes SP, Croxford JL, Mageed RA, Podhajcer OL, Baker D. Chernajovsky Y, et al. Among authors: croxford jl. Drugs Aging. 1998 Jan;12(1):29-41. doi: 10.2165/00002512-199812010-00004. Drugs Aging. 1998. PMID: 9467685 Review.

8

Immuno- and genetic therapy in autoimmune diseases.

Chernajovsky Y, Dreja H, Daly G, Annenkov A, Gould D, Adams G, Croxford JL, Baker D, Podhajcer OL, Mageed RA. Chernajovsky Y, et al. Among authors: croxford jl. Genes Immun. 2000 Jun;1(5):295-307. doi: 10.1038/sj.gene.6363683. Genes Immun. 2000. PMID: 11196690 Review.

9

Cannabinoids control spasticity and tremor in a multiple sclerosis model.

Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L. Baker D, et al. Among authors: croxford jl. Nature. 2000 Mar 2;404(6773):84-7. doi: 10.1038/35003583. Nature. 2000. PMID: 10716447

10

Endocannabinoids control spasticity in a multiple sclerosis model.

Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, Khanolkar A, Layward L, Fezza F, Bisogno T, Di Marzo V. Baker D, et al. Among authors: croxford jl. FASEB J. 2001 Feb;15(2):300-2. doi: 10.1096/fj.00-0399fje. Epub 2000 Dec 8. FASEB J. 2001. PMID: 11156943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page